What is Cresco Labs Debt-to-EBITDA?
Debt-to-EBITDA measures a company’s ability to pay off its debt.
Cresco Labs‘s Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $31.8 Mil. Cresco Labs‘s Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $661.3 Mil. Cresco Labs‘s annualized EBITDA for the quarter that ended in Mar. 2024 was $192.2 Mil. Cresco Labs’s annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 3.60.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast’s BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Cresco Labs‘s Debt-to-EBITDA or its related term are showing as below:
CRLBF’ s Debt-to-EBITDA Range Over the Past 10 Years
Min: -62.84 Med: -3.91 Max: 71.51
Current: 45.64
During the past 13 years, the highest Debt-to-EBITDA Ratio of Cresco Labs was 71.51. The lowest was -62.84. And the median was -3.91.
Cresco Labs Debt-to-EBITDA
